BioSpace News Archive

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2019.

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, will report its fourth quarter and full year 2019 operational and financial results on Thursday, February 27, 2020 after the U.S. financial markets close

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in healthcare total talent solutions, today announced its fourth quarter and full year 2019 financial results.

Cassel’s capabilities amplify TASI Packaging Integrity Group’s customer-focused mission to help ensure packaging quality, protecting end-users worldwide

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the fourth quarter and full year ended December 31, 2019.

Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, announced that it initiated dosing of the second cohort of its Phase 1 multiple ascending dose clinical trial of RGLS4326 for the treatment of autosomal dominant polycystic kidney disease.

DiaMedica Therapeutics Inc. announced the closing of its previously announced underwritten public offering of an aggregate of 2,125,000 shares of its voting common shares at a public offering price of $4.00 per share.

Haydar thinks of translational research as a two-way flow of expertise from the bench to the bedside

Cutera, Inc. announced that it will report financial results for the fourth quarter and full-year 2019 after the market close on Wednesday, February 26, 2020.

Ohana Biosciences announced that Amber Salzman, Ph.D., President and Chief Executive Officer of Ohana, will present a company overview at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at 1:45 p.m. EST in New York, NY.